Mark Bevan, PhD, is a professor of neuroscience at Northwestern University’s Feinberg School of Medicine. His research focuses on the basal ganglia, a group of cells responsible for motor control, and their dysregulation in psychomotor disorders, including Parkinson’s disease (PD) and Huntington’s disease. His laboratory uses a range of molecular, electrophysiological, optogenetic, chemogenetic and imaging approaches. In recent years, his research team has contributed to the understanding of dopamine modulation mechanisms and the effects of dopamine loss on circuit function in PD. Dr. Bevan received his PhD from the University of Manchester and undertook postdoctoral training at the University of Oxford and the University of Tennessee, supported in part by an Advanced Training Fellowship from the Wellcome Trust. In 2012, Dr. Bevan received a Jacob Javits Neuroscience Investigator Award from NIH-NINDS, and in 2016 and 2018 he co-chaired the Basal Ganglia Gordon Research Conference.